Clinical Trials Directory

Trials / Unknown

UnknownNCT06020976

Pattern of Autoimmune Hepatitis in Children In Sohag University Hospital

Status
Unknown
Phase
Study type
Observational
Enrollment
20 (estimated)
Sponsor
Sohag University · Academic / Other
Sex
All
Age
1 Year – 18 Years
Healthy volunteers
Not accepted

Summary

Autoimmune hepatitis (AIH) is a progressive inflammatory liver disorder of unknown etiology. If left untreated, it progresses to liver cirrhosis and liver failure. Diagnosis of AIH relies on the exclusion of other causes of liver disease and the presence of positive clinical, biochemical, and histological criteria. AIH has a very wide spectrum of clinical presentations ranging from being asymptomatic to an acute severe fulminant disease. It may be associated with other autoimmune disorders such as thyroiditis, type 1 diabetes, vitiligo, inflammatory bowel disease, or juvenile idiopathic arthritis. Biochemical features of AIH include elevation of serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), and immunoglobulin G (IgG) in addition to autoantibodies. Liver biopsy is recommended in any patient with suspected autoimmune hepatitis where interface hepatitis is the hallmark of the disease. Immunosuppression is the mainstay of therapy in AIH. Prednisone is administered as the initial therapy either alone or in combination with azathioprine. Liver transplantation is indicated in patients who develop fulminant hepatic failure that is unresponsive to corticosteroids and in patients who develop end-stage liver disease.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTliver biobsyall pationt will be subjected yo liver biobsy to confirm diagnosis

Timeline

Start date
2023-09-10
Primary completion
2024-09-10
Completion
2024-09-10
First posted
2023-09-01
Last updated
2023-09-01

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06020976. Inclusion in this directory is not an endorsement.